QKI: A Potential Drug Target and Biomarker for Q globulin binding RNA

Target Name: QKI

NCBI ID: G9444

QKI: A Potential Drug Target and Biomarker for Q globulin binding RNA

Introduction

Q globulin (Q proteins) is a type of protein that is widely present in cells. They play a key role in biological processes such as cell signaling, metabolic regulation, and immune response. Among the Q globulin family, QKi (Q protein kinase-like) is a new type of transcription factor with strong expression patterns in various cancers. In recent years, studies have found that QKi has broad application prospects in the field of drug research and development as potential drug targets or biomarkers. This article aims to explain the structure, function, pharmacological significance of QKi and its application in drug target screening and biomarker research.

1. The secondary structure of QKi and its RNA-binding characteristics

The secondary structure of QKi appears as an 伪-helix composed of 119 amino acids, and its unique secondary structure domain gives it a higher three-dimensional structure. The active center of QKi is located in the 伪-helical region in the center of the helix. This region has high denaturation sensitivity, allowing QKi to bind to a variety of RNAs, including mRNA, rRNA, and tRNA. In addition, the active center of QKi is rich in sulfhydryl groups, which is beneficial to binding to RNA molecules with sulfhydryl groups.

2. Binding mode of QKi and RNA and its biological function

1. Binding of QKi to mRNA

mRNA is the direct template for gene expression, and QKi can regulate gene transcription by binding to mRNA. In cells, the binding site of QKi to mRNA is mainly located in the promoter region of mRNA. This region contains multiple elements that bind to transcription initiation factors, such as TFII, ATF and RNA-binding proteins. After QKi binds to mRNA, it can activate these transcription factors, thereby promoting gene expression. In addition, the stability of QKi binding to mRNA is high, which is beneficial to improving the specificity of the drug to its target.

2. Binding of QKi and rRNA

rRNA is an important component of ribosomes and participates in the protein synthesis process. QKi can affect the formation and function of ribosomes by binding to rRNA. This process mainly involves the protein components that QKi binds to rRNA, such as ribosomes A and P. After QKi binds to rRNA, it can inhibit the formation of ribosomes, thereby inhibiting protein synthesis and achieving the anti-tumor effect of the drug.

3. Binding of QKi and tRNA

tRNA is a molecule that carries amino acids and participates in protein synthesis. QKi can affect the binding and modification of amino acids by binding to tRNA. This process mainly involves the protein components that QKi binds to tRNA, such as histones. After QKi binds to tRNA, it can affect the binding of amino acids, thereby changing the structure and function of the protein. In addition, the stability of QKi binding to tRNA is high, which is beneficial to improving the specificity of the drug to the target.

4. Combination of QKi and DNA

QKi can also participate in gene transcription and regulation by binding to DNA. This process mainly involves the protein components that QKi binds to DNA, such as histones. After QKi binds to DNA, it can affect the unwinding and binding of DNA, thereby changing gene expression. In addition, the stability of QKi binding to DNA is high, which is beneficial to improving the specificity of drugs to their targets.

3. Application of QKi in drug target screening

1. Drug target screening

Drug target screening is an important part of drug research. As a new type of transcription factor, QKi has broad application prospects. By studying the binding mode of QKi and RNA and its biological function, we can speculate on the drug targets that QKi may involve. For example, QKi may bind to molecules such as mRNA, rRNA, and tRNA in tumor cells, thereby affecting the gene expression of tumor cells. Therefore, QKi can be screened as a potential drug target.

2. Biomarker research

Biomarkers refer to something that can reflect something in an organism

Protein Name: QKI, KH Domain Containing RNA Binding

Functions: RNA-binding protein that plays a central role in myelinization (PubMed:16641098). Binds to the 5'-NACUAAY-N(1,20)-UAAY-3' RNA core sequence. Regulates target mRNA stability (PubMed:23630077). In addition, acts by regulating pre-mRNA splicing, mRNA export and protein translation. Required to protect and promote stability of mRNAs such as MBP and CDKN1B. Regulator of oligodendrocyte differentiation and maturation in the brain that may play a role in myelin and oligodendrocyte dysfunction in schizophrenia (PubMed:16641098). Participates in mRNA transport by regulating the nuclear export of MBP mRNA. Also involved in regulation of mRNA splicing of MAG pre-mRNA. Acts as a translational repressor (By similarity)

More Common Targets